Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana

Launched by HILLEROD HOSPITAL, DENMARK · May 1, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new smartphone app called Picterus, which is designed to help detect neonatal jaundice in newborns. Neonatal jaundice is a common condition where a baby’s skin and eyes appear yellow due to high levels of a substance called bilirubin. The goal of this study is to see if the app can provide accurate and affordable bilirubin estimates using digital images taken with a smartphone, especially in a population in Botswana.

To participate, infants need to be at least 24 hours old and less than 14 days old, weigh between 2000 and 4500 grams, and be born after 37 weeks of pregnancy. The study is looking for babies who may already need a blood test for jaundice or other screenings. However, infants who have serious skin issues, have recently undergone certain treatments, or have specific medical conditions may not be eligible. If you join the study, you can expect a simple and friendly process to help improve how neonatal jaundice is detected, potentially benefiting other babies in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Gestational age \> 37 weeks
• • Birth weight \> 2000 g and \< 4500 g
• • Age \> 24 hours and \< 14 days
• • Infants requiring a blood sample for clinically suspected jaundice or other screening
• Exclusion Criteria:
• • Infants transferred to the pediatric ward for advanced treatment
• • Infants with a skin rash or other disease that affects the skin where measurements are performed
• • Infants that receive or have received phototherapy in the last 24 hours
• • Infants with an inborn disease